Clinical Trials Browser

Phase 1 × Breast Neoplasms × Interleukin 1 Receptor Antagonist Protein × Clear all

NCT01802970 2021-10-08

Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients

Phase 1 Completed

Breast Neoplasms